BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 35286235)

  • 1. LEM domain containing 1 promotes pancreatic cancer growth and metastasis by p53 and mTORC1 signaling pathway.
    Cao X; Yao N; Zhao Z; Fu Y; Hu Y; Zhu P; Shi W; Tang L
    Bioengineered; 2022 Mar; 13(3):7771-7784. PubMed ID: 35286235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEM domain containing 1 promotes proliferation via activating the PI3K/Akt signaling pathway in gastric cancer.
    Li Q; Ge Y; Chen X; Wang L; Xia Y; Xu Z; Li Z; Wang W; Yang L; Zhang D; Xu Z
    J Cell Biochem; 2019 Sep; 120(9):15190-15201. PubMed ID: 31021450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA LINC00958 promotes colorectal cancer progression by enhancing the expression of LEM domain containing 1 via microRNA miR-3064-5p.
    Luo Z; Hao S; Yuan J; Zhu K; Liu S; Zhang J; Yao L
    Bioengineered; 2021 Dec; 12(1):8100-8115. PubMed ID: 34672237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LEM domain containing 1 (LEMD1) transcriptionally activated by SRY-related high-mobility-group box 4 (SOX4) accelerates the progression of colon cancer by upregulating phosphatidylinositol 3-kinase (PI3K)/protein kinase B (Akt) signaling pathway.
    Li D; Wang D; Liu H; Jiang X
    Bioengineered; 2022 Apr; 13(4):8087-8100. PubMed ID: 35294319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevation of LEM Domain Containing 1 Predicts Poor Prognosis of NSCLC Patients and Triggers Malignant Stemness and Invasion of NSCLC Cells by Stimulating PI3K/AKT Pathway.
    Li L; Zhang P
    Curr Mol Med; 2024; 24(3):366-378. PubMed ID: 36967459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sushi Repeat Containing Protein X-linked 2 Is a Downstream Signal of LEM Domain Containing 1 and Acts as a Tumor-Promoting Factor in Oral Squamous Cell Carcinoma.
    Sasahira T; Kurihara-Shimomura M; Nishiguchi Y; Shimomura H; Kirita T
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32455867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.
    Sasahira T; Kurihara M; Nakashima C; Kirita T; Kuniyasu H
    Br J Cancer; 2016 Jun; 115(1):52-8. PubMed ID: 27280633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer.
    Zhang H; Zhang X; Li X; Meng WB; Bai ZT; Rui SZ; Wang ZF; Zhou WC; Jin XD
    J Cell Physiol; 2018 Jan; 234(1):619-631. PubMed ID: 30069972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis.
    Zhang X; Zhang P; An L; Sun N; Peng L; Tang W; Ma D; Chen J
    Acta Pharm Sin B; 2020 Aug; 10(8):1397-1413. PubMed ID: 32963939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional analysis of variants of a cancer/testis antigen LEMD1 in colorectal cancer stem-like cells.
    Takeda R; Hirohashi Y; Shen M; Wang L; Ogawa T; Murai A; Yamamoto E; Kubo T; Nakatsugawa M; Kanaseki T; Tsukahara T; Nishidate T; Okita K; Kutomi G; Sato N; Takemasa I; Torigoe T
    Biochem Biophys Res Commun; 2017 Apr; 485(3):651-657. PubMed ID: 28219643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

  • 13. TMEM158 promotes pancreatic cancer aggressiveness by activation of TGFβ1 and PI3K/AKT signaling pathway.
    Fu Y; Yao N; Ding D; Zhang X; Liu H; Ma L; Shi W; Zhu C; Tang L
    J Cell Physiol; 2020 Mar; 235(3):2761-2775. PubMed ID: 31531884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of LINC00261 upregulation on the pancreatic cancer EMT process is mediated by KLF13 via the mTOR signaling pathway.
    Li B; Pang S; Dou J; Zhou C; Shen B; Zhou Y
    Clin Transl Oncol; 2022 Jun; 24(6):1059-1072. PubMed ID: 35066757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
    Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
    Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial cell adhesion molecule (EpCAM) is associated with prostate cancer metastasis and chemo/radioresistance via the PI3K/Akt/mTOR signaling pathway.
    Ni J; Cozzi P; Hao J; Beretov J; Chang L; Duan W; Shigdar S; Delprado W; Graham P; Bucci J; Kearsley J; Li Y
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2736-48. PubMed ID: 24076216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LEM domain containing 1 promotes thyroid cancer cell proliferation and migration by activating the Wnt/β-catenin signaling pathway and epithelial-mesenchymal transition.
    Xu M; Lin B; Zheng D; Wen J; Hu W; Li C; Zhang X; Zhang X; Qu J
    Oncol Lett; 2021 Jun; 21(6):442. PubMed ID: 33868480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEMD1-AS1 Suppresses Ovarian Cancer Progression Through Regulating miR-183-5p/TP53 Axis.
    Guo R; Qin Y
    Onco Targets Ther; 2020; 13():7387-7398. PubMed ID: 32801762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a novel PAK1 inhibitor to treat pancreatic cancer.
    Wang J; Zhu Y; Chen J; Yang Y; Zhu L; Zhao J; Yang Y; Cai X; Hu C; Rosell R; Sun X; Cao P
    Acta Pharm Sin B; 2020 Apr; 10(4):603-614. PubMed ID: 32322465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.